|

EFFECT OF ESWT ON BREAST-CANCER RELATED LYMPHEDEMA

RECRUITINGN/ASponsored by Ankara City Hospital Bilkent
Actively Recruiting
PhaseN/A
SponsorAnkara City Hospital Bilkent
Started2024-11-20
Est. completion2026-10-14
Eligibility
Age18 Years+
SexFEMALE
Healthy vol.Accepted

Summary

The aim of this study is to evaluate the effectiveness of extracorporeal shock wave therapy (ESWT) combined with complete decongestive therapy (CDT) compared with CDT alone in patients with breast cancer-related lymphedema. Female patients with unilateral Stage II upper-extremity lymphedema related to breast cancer will be included. Participants will receive either complete decongestive therapy alone or complete decongestive therapy combined with extracorporeal shock wave therapy. Clinical outcomes will be evaluated before treatment, immediately after treatment, and at 1 and 3 months after treatment. Primary outcomes will include limb circumference difference, volumetric measurements, and ultrasonographic assessment of skin and subcutaneous tissue thickness. Secondary outcomes will include upper-extremity function, quality of life, and pain.

Eligibility

Age: 18 Years+Sex: FEMALEHealthy volunteers accepted
Inclusion Criteria:Female patients with unilateral upper-extremity lymphedema related to breast cancer.

At least 2 years have elapsed since the diagnosis of breast cancer, cancer treatment has been completed, and cure has been documented during oncology follow-up.

Stage II lymphedema according to the International Society of Lymphology classification.

Duration of lymphedema of less than 4 years.

Voluntary participation in the study. -

Exclusion Criteria: Poor general health status.

Open wounds, sensory deficits, or other conditions in the treatment area that may constitute a contraindication to treatment.

Active infection.

Presence of metastasis.

Bilateral breast cancer.

Bilateral lymphedema.

Use of anticoagulant therapy or presence of a coagulation disorder.

Cognitive impairment that may prevent completion of study assessment procedures.

Physical therapy, including electrotherapy or exercise therapy, ESWT, or regular use of nonsteroidal anti-inflammatory drugs within the previous 6 months.

Systemic inflammatory or autoimmune disorders such as rheumatoid arthritis or systemic lupus erythematosus.

\-

Conditions3

Breast CancerBreast Cancer Related LymphedemaCancer

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.